<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923153</url>
  </required_header>
  <id_info>
    <org_study_id>MustafaKU 2</org_study_id>
    <nct_id>NCT03923153</nct_id>
  </id_info>
  <brief_title>Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina</brief_title>
  <official_title>Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stable angina is a cardiac pathology that adversely affects the quality of life of the&#xD;
      patient, which develops as a result of narrowing of the coronary vessels developing in&#xD;
      atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely&#xD;
      investigated the effects of exercise training in patients with stable angina. No study&#xD;
      investigated the effects of inspiratory muscle training in patients with stable&#xD;
      angina.Investigators aimed to investigate the effects of inspiratory muscle training on&#xD;
      aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP)&#xD;
      muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with stable angina will be included. Primary outcome measurement is inspiratory&#xD;
      muscle strength, secondary outcomes are functional exercise capacity, peripheral muscle&#xD;
      strength, pulmonary functions, maximal exercise capacity, fatigue, quality of life,&#xD;
      depression.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Actual">August 30, 2020</completion_date>
  <primary_completion_date type="Actual">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Mouth pressure device( MicroRPM, Micro Medical England)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Functional exercise capacity at 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>6 minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Pulmonary functions at 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Change from baseline Fatigue Severity Scale (FSS) (Turkish version of scale) at 8 weeek.&#xD;
Patient choose a number from 1 to 7 that indicates how much the patient agrees with each statement, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 4 or higher generally indicates severe fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Baseline,after 8 week</time_frame>
    <description>Change from baseline Montgomery Asberg Depression Rating Scale (MADRS) (Turkish version of scale) at 8 week.&#xD;
This assessment tool contains 10 items with a score from 0 to 6, thus the maximum score is 60. A higher score indicates a more severe depression.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality life</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Change of baseline quality of life at 8 week .Short Form (SF-36) Health Survey (Turkish version of scale) The SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). For each dimension item scores are coded, summed, and transformed on to a scale from 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Angina, Stable</condition>
  <arm_group>
    <arm_group_label>Inspiratory muscle training group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inspiratory muscle training group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)</intervention_name>
    <description>Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP).&#xD;
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.&#xD;
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.</description>
    <arm_group_label>Inspiratory muscle training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)</intervention_name>
    <description>Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP).&#xD;
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.&#xD;
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.</description>
    <arm_group_label>Sham group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No contraindication for pulmonary physiotherapy&#xD;
&#xD;
          -  Anjina patients who are clinically stable&#xD;
&#xD;
          -  have no other disease that may affect respiratory function&#xD;
&#xD;
          -  Individuals who have the good cooperation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under the age of 18&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Patients with known malignancies&#xD;
&#xD;
          -  patients without consent&#xD;
&#xD;
          -  known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF &lt;40%)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aysel yıldız, assoc prof</last_name>
    <role>Study Director</role>
    <affiliation>Marmara University Faculty of Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Irem Hüzmeli, Msc</last_name>
    <role>Study Chair</role>
    <affiliation>Mustafa Kemal University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oğuz Akkuş, assist prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>hatay mustafa kemal university Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatih Yalçın, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>hatay mustafa kemal university Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hatay Mustafa Kemal University</name>
      <address>
        <city>Hatay</city>
        <state>Merkez</state>
        <zip>31010</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Kellens I, Cannizzaro F, Gouilly P, Crielaard JM. [Inspiratory muscles strength training in recreational athletes]. Rev Mal Respir. 2011 May;28(5):602-8. doi: 10.1016/j.rmr.2011.01.008. Epub 2011 Apr 19. French.</citation>
    <PMID>21645830</PMID>
  </reference>
  <reference>
    <citation>Long L, Anderson L, Dewhirst AM, He J, Bridges C, Gandhi M, Taylor RS. Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev. 2018 Feb 2;2:CD012786. doi: 10.1002/14651858.CD012786.pub2. Review.</citation>
    <PMID>29394453</PMID>
  </reference>
  <reference>
    <citation>American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624.</citation>
    <PMID>12186831</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2019</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>Irem Hüzmeli</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <keyword>inspiratory muscle trainig</keyword>
  <keyword>quality of life</keyword>
  <keyword>aerobic capacity</keyword>
  <keyword>depression</keyword>
  <keyword>fatique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

